U.S. markets close in 6 hours 8 minutes
  • S&P 500

    3,781.51
    +13.04 (+0.35%)
     
  • Dow 30

    31,060.26
    +136.12 (+0.44%)
     
  • Nasdaq

    12,705.89
    -17.59 (-0.14%)
     
  • Russell 2000

    2,165.48
    +18.56 (+0.86%)
     
  • Crude Oil

    65.94
    +2.11 (+3.31%)
     
  • Gold

    1,695.40
    -5.30 (-0.31%)
     
  • Silver

    25.25
    -0.22 (-0.85%)
     
  • EUR/USD

    1.1922
    -0.0057 (-0.48%)
     
  • 10-Yr Bond

    1.5920
    +0.0420 (+2.71%)
     
  • GBP/USD

    1.3827
    -0.0067 (-0.48%)
     
  • USD/JPY

    108.3750
    +0.3990 (+0.37%)
     
  • BTC-USD

    48,494.27
    -1,095.48 (-2.21%)
     
  • CMC Crypto 200

    969.35
    +26.18 (+2.78%)
     
  • FTSE 100

    6,691.81
    +40.93 (+0.62%)
     
  • Nikkei 225

    28,864.32
    -65.78 (-0.23%)
     

Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

MONTREAL and CHARLOTTE, N.C., Feb. 25, 2021 /CNW/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the following investor conferences:

  • The Cowen 41st Annual Health Care Conference's panel on Cardiovascular Disease and Hospital Products on Thursday, March 4, 2021 at 1:30 p.m. Eastern Time.

  • The H.C. Wainwright Global Life Sciences Conference on Tuesday, March 9, 2021 on demand beginning at 7:00 a.m. Eastern Time.

  • The Oppenheimer 31st Annual Healthcare Conference on Tuesday, March 16, 2021 at 10:00 a.m. Eastern Time.

A replay of the pre-recorded H.C. Wainwright presentation and live webcast Oppenheimer presentation can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com. An archived replay of the webcasts will be available on the same website for approximately 90 days following the presentations.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of etripamil, a Phase 3 clinical-stage program, for the treatment of cardiovascular indications. Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma.

Contact

David Pitts
Argot Partners
212-600-1902
david@argotpartners.com

(PRNewsfoto/Milestone Pharmaceuticals)
(PRNewsfoto/Milestone Pharmaceuticals)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-301235125.html

SOURCE Milestone Pharmaceuticals, Inc.

Cision
Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2021/25/c9767.html